X4 Pharmaceuticals, Inc (XFOR)

CIK 1501697 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for X4 Pharmaceuticals, Inc.

Recent SEC filings

FiledFormAccession number
Sep 9, 20268-K0001501697-26-000076
Sep 8, 20268-K0001501697-26-000072
Aug 14, 2026SCHEDULE 13G/A0001193125-26-352651
Aug 14, 2026SCHEDULE 13G/A0001172661-26-003487
Aug 13, 20261440001339498-26-000003
Aug 13, 202640001501697-26-000070
Aug 13, 202640001501697-26-000069
Aug 13, 20261440002081729-26-000004
Aug 6, 202610-Q0001501697-26-000068
Jul 30, 2026SCHEDULE 13G0002012383-26-003133
Jul 1, 20268-K0001501697-26-000060
Jul 1, 202640001501697-26-000065
Jul 1, 202630001501697-26-000063
Jul 1, 202640001501697-26-000064
May 15, 2026SCHEDULE 13G/A0001193125-26-226568
May 14, 2026EFFECT9999999995-26-001669
May 13, 202640001501697-26-000049
May 13, 20268-K/A0001501697-26-000051
May 12, 20268-K0001501697-26-000047
May 12, 20261440001276750-26-000004
May 6, 202610-Q0001501697-26-000040
May 6, 2026S-30001501697-26-000043
Mar 20, 2026DEFA14A0001501697-26-000032
Mar 20, 2026DEF 14A0001501697-26-000031
Mar 20, 2026ARS0001501697-26-000033